Tumor Markers 2019: Supplier Shares, Strategic Assessments of Current and Emerging Competitors

This new 80-page report provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include:
  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.


- Abbott
- AdnaGen/Alere
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco

- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila

2024 US Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

This new report from contains 567 pages and 50 tables.The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis of

USD 3500 View Report

2024 UK Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

This new report from  contains 527 pages and 37 tables.The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis

USD 3500 View Report

2024 US Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

This new report from contains 567 pages and 50 tables.The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis of

USD 3500 View Report

2024 UK Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

This new report from  contains 527 pages and 37 tables.The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis

USD 3500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available